PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS

Title:

PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS

Document Type and Number:

WIPO Patent Application WO2001019829

Kind Code:

A3

Abstract:

The present invention provides compounds of Formula (I), including pharmaceutically acceptable salts and/or prodrugs thereof, where G, Ra, R2, R3 are defined as described herein and their use as protein Kinase inhibitors.

More Like This:

WO/2012/069442	DIPHENYL-AMINE DERIVATIVES: USES, PROCESS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS
JP7110232	Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compound
JP6353530	Carbazole carboxamide compounds useful as kinase inhibitors

Inventors:

HIRST GAVIN C (US)
CALDERWOOD DAVID (US)
WISHART NEIL (US)
RAFFERTY PAUL (US)
RITTER KURT (US)
ARNOLD LEE D (US)
FRIEDMAN MICHAEL M (US)

Application Number:

PCT/US2000/025468

Publication Date:

September 27, 2001

Filing Date:

September 15, 2000

Export Citation:

Click for automatic bibliography generation Help

Assignee:

BASF AG (DE)
HIRST GAVIN C (US)
CALDERWOOD DAVID (US)
WISHART NEIL (US)
RAFFERTY PAUL (US)
RITTER KURT (US)
ARNOLD LEE D (US)
FRIEDMAN MICHAEL M (US)

International Classes:

A61K31/519; A61K31/5377; A61K38/22; A61P1/04; A61P1/16; A61P3/10; A61P5/14; A61P7/06; A61P9/00; A61P9/10; A61P11/00; A61P11/06; A61P13/00; A61P13/12; A61P15/16; A61P17/02; A61P17/06; A61P19/02; A61P25/00; A61P27/02; A61P29/00; A61P31/04; A61P31/22; A61P33/02; A61P35/00; A61P35/02; A61P37/06; A61P43/00; C07D487/04; C07F9/6561; (IPC1-7): C07D487/04; A61K31/519; A61P35/00

Domestic Patent References:

WO1996031510A1

1996-10-10

Foreign References:

US5593997A

1997-01-14

Download PDF:

View/Download PDF PDF Help

Previous Patent: KINASE INHIBITORS AS THERAPEUTIC AGENTS

Next Patent: THIENOISOXAZOLE PHENOXY UNSUBSTITUTED ETHYL AND PROPYL DERIVATIVES USEFUL AS D4 ANTAGONISTS